STING1 and neoplasm: Luo et al. have reported a versatile nanovaccine platform, in which a synthetic polymeric nanoparticle PC7A enhances cross-presentation of antigens, transports antigens to lymph nodes and functions as an immunogenic, tumor-suppressive adjuvant by activating “Stimulator of Interferon Genes” (STING) pathways (142).